US Stock MarketDetailed Quotes

IBIO iBio Inc

Watchlist
  • 2.4500
  • +0.0400+1.66%
Close Dec 27 16:00 ET
  • 2.4900
  • +0.0400+1.63%
Post 20:01 ET
22.42MMarket Cap-1.13P/E (TTM)

About iBio Inc Company

iBio, Inc. is an AI-driven innovator that develops next-generation biopharmaceuticals using computational biology and 3D-modeling of subdominant and conformational epitopes, prospectively enabling the discovery of new antibody treatments for hard to target cancers, and other diseases. It focuses on decreasing drug failures, shortening drug development timelines and opening up new frontiers against the most promising targets. The company was founded on April 17, 2008 and is headquartered in San Diego, CA.

Company Profile

SymbolIBIO
Company NameiBio Inc
Listing DateJan 4, 2011
Founded1993
CEODr. Martin B. Brenner, PhD
MarketAMEX
Employees16
Fiscal Year Ends06-30
Address11750 Sorrento Valley Road,Suite 200
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-979-446-0027
Websitehttp://www.ibioinc.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Martin B. Brenner, PhD
  • Director, Chief Executive Officer and Chief Scientific Officer
  • 1.27M
  • Felipe Duran
  • Chief Financial Officer and Principal Accounting Officer
  • 761.87K
  • William D. Clark
  • Chairman of the Board
  • 89.08K
  • General James T. Hill, (Ret.)
  • Independent Director
  • 55.00K
  • Dr. Alexandra Kropotova, M.D.
  • Independent Director
  • 52.50K
  • David A. Arkowitz, M.B.A.
  • Independent Director
  • --
  • Gary L. Sender
  • Independent Director
  • 66.00K
  • Evert B. Schimmelpennink
  • Independent Director
  • 56.67K
  • Antonio Parada
  • Independent Director
  • --
  • Marc Banjak
  • Chief Legal Counsel
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data